insights into nkg2d-targeting car-t cells in r/r aml
Published 1 year ago • 136 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
2:21
nkg2d-based car-t in r/r aml and mds
-
1:52
opportunities and challenges for dual-targeting car-t therapy in all
-
1:19
insights into rapid car-t manufacturing processes and challenges in this space
-
4:03
think trial: phase i results for nkg2d car-t therapy in aml
-
1:06
insights into toll-like receptor signaling and implications for car-t therapy
-
3:18
evaluating dual-targeting cd19/22 car-t cells in patients with r/r all
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
4:20
an insight into the use of car-nks for the treatment of aml
-
1:01:36
deciphering car-t cells: exploring functional mechanisms to drive next generation immunotherapy
-
3:14
car t-cell therapy explained (manufacturing process & how it works)
-
9:39
what are dual car-t cells?
-
3:52
nkg2d car t-cells & soluble nkg2d ligands
-
3:52
nkg2d car t-cells & soluble nkg2d ligands
-
2:20
design of a phase i trial of allogeneic anti-cd123 car t-cells in r/r aml
-
1:08
the benefits of car-t therapy in 2l over 3l in r/r dlbcl
-
1:38
challenges of car-t therapy in the real-world setting
-
1:55
developing the next generation of car-t cells
-
0:46
scaling up car-t manufacturing with automation and digitalization
-
1:06
novel third-generation tlr2 co-stimulatory car-t cells for b-cell malignancies
-
4:41
novel treatment approaches in bpdcn: the promise of cd123-targeting allogeneic car-t cells
-
2:12
expanding the reach of car-t
-
1:02
the use of car-t cell products in a real-world setting